Ranolazine: Started Phase III

CV Therapeutics Inc. (CVTX), Palo Alto, Calif.
Product: Ranolazine
Business: Cardiovascular
Therapeutic category: Metabolism
Target: NA

Read the full 167 word article

How to gain access

Continue reading with a
two-week free trial.